Přehled o publikaci
2024
Adjuvant radiotherapy after brain metastasectomy: analysis of consecutive cohort of 118 patients from real world practice
FADRUS, Pavel; Václav VYBÍHAL; Ivana ROŠKOVÁ; Iveta SELINGEROVÁ; Martin SMRČKA et. al.Basic information
Original name
Adjuvant radiotherapy after brain metastasectomy: analysis of consecutive cohort of 118 patients from real world practice
Authors
FADRUS, Pavel; Václav VYBÍHAL; Ivana ROŠKOVÁ; Iveta SELINGEROVÁ; Martin SMRČKA; Radim JANČÁLEK; Jiří ŠÁNA; Ondřej SLABÝ; Petr POSPÍŠIL; Ludmila HYNKOVÁ; Jan GARCIC; Renata BELANOVÁ; Jan KRISTEK; Andrea ŠPRLÁKOVÁ-PUKOVÁ; Zdeněk MACKERLE; Vilém JURÁŇ; Marek SOVA; Eduard NEUMAN; Hana VALEKOVÁ; Radek LAKOMÝ; Miloš HOLÁNEK; Roman HRSTKA; Michaela ŠVAJDOVÁ; Kateřina POLÁCHOVÁ; Ivana KOLOUŠKOVÁ; Pavel ŠLAMPA and Tomáš KAZDA
Edition
Reports of Practical Oncology and Radiotherapy, GDANSK, VIA MEDICA, 2024, 1507-1367
Other information
Language
English
Type of outcome
Article in a journal
Country of publisher
Poland
Confidentiality degree
is not subject to a state or trade secret
References:
RIV identification code
RIV/00216224:14110/24:00136239
Organization
Lékařská fakulta – Repository – Repository
UT WoS
001293214500001
EID Scopus
2-s2.0-85188780134
Keywords in English
brain metastases; surgery; radiotherapy; tumor cavity; overall survival
Links
LX22NPO5102, research and development project. NU22-03-00159, research and development project. NV18-03-00469, research and development project. BBMRI.cz IV, large research infrastructures. CZECRIN IV, large research infrastructures.
Changed: 10/6/2025 00:50, RNDr. Daniel Jakubík
Abstract
In the original language
lt; 0.001; hazard ratio (HR) 0.47, p = 0.004] with median follow-up of 58 months. Cumulative incidence for local, distant, and extracranial control was not significantly different between groups, with 12-month cumulative control of 22% vs. 18%, 44% vs. 29%, and 35% vs. 32% for stereotactic and WBRT group, respectively. WBRT was an independent factor for better distal brain control. Conclusions: Real world data demonstrating significantly better overall survival in patients treated with postoperative targeted radiotherapy compared with postoperative WBRT is presented, with no significant difference in cumulative incidence for local or distant brain control. The majority of patients with targeted radiotherapy had a fractionated dose schedule with outcomes comparable to single-dose radiation trials of postoperative targeted radiotherapy.